Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jacques Neefjes

Showing results (191-200 of 211) with videos related to

Pageof 22
Sort By:
Bioorganic & Medicinal Chemistry|January 22, 2019
Comprehensive structure-activity-relationship of azaindoles as highly potent FLT3 inhibitorsSebastian H Grimm, Berend Gagestein, Jordi F Keijzer, et al.
The EMBO Journal|July 31, 2023
RNF26 binds perinuclear vimentin filaments to integrate ER and endolysosomal responses to proteotoxic stressTom Cremer, Lenard M Voortman, Erik Bos, et al.
Nature|November 30, 2007
Intracellular bacterial growth is controlled by a kinase network around PKB/AKT1Coenraad Kuijl, Nigel D L Savage, Marije Marsman, et al.
Cell|November 27, 2012
MED12 controls the response to multiple cancer drugs through regulation of TGF-β receptor signalingSidong Huang, Michael Hölzel, Theo Knijnenburg, et al.
ACS Chemical Biology|August 29, 2023
Cellular Validation of a Chemically Improved Inhibitor Identifies Monoubiquitination on OTUB2Jin Gan, Jelle de Vries, Jimmy J L L Akkermans, et al.
Stem Cell Reports|August 4, 2023
CRB1 is required for recycling by RAB11A+ vesicles in human retinal organoidsThilo M Buck, Peter M J Quinn, Lucie P Pellissier, et al.
Cell Reports|December 4, 2023
The MHC-E peptide ligands for checkpoint CD94/NKG2A are governed by inflammatory signals, whereas LILRB1/2 receptors are peptide indifferentJim Middelburg, Soroush Ghaffari, Tom A W Schoufour, et al.
Nature Communications|February 4, 2026
Metabolic engineering of doxorubicin biosynthesis through P450-redox partner optimization and structural analysis of DoxAArina Koroleva, Erika Artukka, Keith Yamada, et al.
Journal for Immunotherapy of Cancer|March 10, 2022
Enhanced antigen cross-presentation in human colorectal cancer-associated fibroblasts through upregulation of the lysosomal protease cathepsin STom J Harryvan, Marten Visser, Linda de Bruin, et al.
Elife|December 8, 2022
DNA damage independent inhibition of NF-κB transcription by anthracyclinesAngelo Ferreira Chora, Dora Pedroso, Eleni Kyriakou, et al.
Pageof 22

Showing results (191-200 of 211) with videos related to

Sort By:
Pageof 22
Bioorganic & Medicinal Chemistry|January 22, 2019
Comprehensive structure-activity-relationship of azaindoles as highly potent FLT3 inhibitorsSebastian H Grimm, Berend Gagestein, Jordi F Keijzer, et al.
The EMBO Journal|July 31, 2023
RNF26 binds perinuclear vimentin filaments to integrate ER and endolysosomal responses to proteotoxic stressTom Cremer, Lenard M Voortman, Erik Bos, et al.
Nature|November 30, 2007
Intracellular bacterial growth is controlled by a kinase network around PKB/AKT1Coenraad Kuijl, Nigel D L Savage, Marije Marsman, et al.
Cell|November 27, 2012
MED12 controls the response to multiple cancer drugs through regulation of TGF-β receptor signalingSidong Huang, Michael Hölzel, Theo Knijnenburg, et al.
ACS Chemical Biology|August 29, 2023
Cellular Validation of a Chemically Improved Inhibitor Identifies Monoubiquitination on OTUB2Jin Gan, Jelle de Vries, Jimmy J L L Akkermans, et al.
Stem Cell Reports|August 4, 2023
CRB1 is required for recycling by RAB11A+ vesicles in human retinal organoidsThilo M Buck, Peter M J Quinn, Lucie P Pellissier, et al.
Cell Reports|December 4, 2023
The MHC-E peptide ligands for checkpoint CD94/NKG2A are governed by inflammatory signals, whereas LILRB1/2 receptors are peptide indifferentJim Middelburg, Soroush Ghaffari, Tom A W Schoufour, et al.
Nature Communications|February 4, 2026
Metabolic engineering of doxorubicin biosynthesis through P450-redox partner optimization and structural analysis of DoxAArina Koroleva, Erika Artukka, Keith Yamada, et al.
Journal for Immunotherapy of Cancer|March 10, 2022
Enhanced antigen cross-presentation in human colorectal cancer-associated fibroblasts through upregulation of the lysosomal protease cathepsin STom J Harryvan, Marten Visser, Linda de Bruin, et al.
Elife|December 8, 2022
DNA damage independent inhibition of NF-κB transcription by anthracyclinesAngelo Ferreira Chora, Dora Pedroso, Eleni Kyriakou, et al.
Pageof 22